Jonathan Cohen
Chairman chez MESHEK ENERGY - RENEWABLE ENERGIES LTD.
Fortune : 620 459 $ au 31/03/2024
Profil
Jonathan Cohen is currently the Chief Executive Officer of Negev Agro, Inc. He is also the Chairman of Hazera (1939) Ltd., Negev Residences - Central Cooperative Agriculture Ltd., Meshek Energy - Renewable Energies Ltd., Mishkei Renewable Energies Ltd., Bionichive Ltd., and Alma Bio Therapeutics.
He previously served as the Chief Executive Officer of The Arava Power Co. Ltd.
and Ardom Property.
Cohen holds a Master's in Business Administration from the University of Bradford and an undergraduate degree from Tel-Aviv University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/08/2023 | 748 000 ( 0,11% ) | 620 459 $ | 31/03/2024 |
Postes actifs de Jonathan Cohen
| Sociétés | Poste | Début |
|---|---|---|
| MESHEK ENERGY - RENEWABLE ENERGIES LTD. | Chairman | 08/03/2020 |
| Negev Agro, Inc. | Chief Executive Officer | 28/12/2010 |
Bionichive Ltd.
 Bionichive Ltd. Auto Parts: OEMProducer Manufacturing Bionichive Ltd. introduces Squid, a fully automated, autonomous robotic solution that combines the intelligence and flexibility of humans with the power and efficiency of robots. The company is based in Ein Habsor, Israel. The Israeli company's solution is capable of pick and put-away, floor to ceiling and retrofits onto any existing warehouse. A high-end embedded control system and smart real-time data analysis allows Bionichive’s algorithmic engine to dynamically learn problems created in one warehouse and apply resolutions to all warehouses in the network. Bionichive offers a solution based on a fleet of autonomous robots, capable of floor to ceiling pick and put-away while working alongside the labor force on existing operations. | Chairman | 01/01/2020 |
| Hazera (1939) Ltd. | Chairman | 01/01/2016 |
| Mishkei Renewable Energies Ltd. | Chairman | 01/01/2016 |
Alma Bio Therapeutics
 Alma Bio Therapeutics Miscellaneous Commercial ServicesCommercial Services Alma Bio Therapeutics is a French company that aims to restore immune resilience in patients suffering from autoimmune diseases. The private company's therapeutic approach employs the language of the immune system to improve patients' health by targeting the underlying cause of the disease. The company's treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission. Alma Bio Therapeutics has developed a breakthrough therapy that is targeted, specific, and confined to the site of disease, reinstating immune balance with no overdrive or complete suppression. The company's platform-technology is applicable to several autoimmune diseases, promising to yield a versatile pipeline. The company's lead programs are directed towards diseases of complex etiology in areas of significant unmet clinical need, with inflammatory bowel disease (IBD) as their first clinical indication. Alma Bio Therapeutics is led by a seasoned management team with extensive expertise in business development, drug development, and technology commercialization. | Chairman | 01/01/2019 |
| Negev Residences - Central Cooperative Agriculture Ltd. | Chairman | 01/01/2016 |
Anciens postes connus de Jonathan Cohen
| Sociétés | Poste | Fin |
|---|---|---|
| Ardom Property | President | - |
The Arava Power Co. Ltd.
 The Arava Power Co. Ltd. Electric UtilitiesUtilities Arava Power Co. Ltd. engages in the solar power generation. It designs and manufactures solar modules and mounting and balancing systems. The firm offers management and establishing, maintenance and asset management services. The company was founded by David Rosenblatt, Yosef I. Abramowitz and Ed Hofland in 2006 and is headquartered in Eilot, Israel | Chief Executive Officer | - |
Formation de Jonathan Cohen
| University of Bradford | Masters Business Admin |
| Tel-Aviv University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MESHEK ENERGY - RENEWABLE ENERGIES LTD. | Utilities |
| Entreprise privées | 8 |
|---|---|
The Arava Power Co. Ltd.
The Arava Power Co. Ltd. Electric UtilitiesUtilities Arava Power Co. Ltd. engages in the solar power generation. It designs and manufactures solar modules and mounting and balancing systems. The firm offers management and establishing, maintenance and asset management services. The company was founded by David Rosenblatt, Yosef I. Abramowitz and Ed Hofland in 2006 and is headquartered in Eilot, Israel | Utilities |
| Negev Agro, Inc. | |
| Ardom Property | |
| Hazera (1939) Ltd. | |
| Negev Residences - Central Cooperative Agriculture Ltd. | |
| Mishkei Renewable Energies Ltd. | |
Bionichive Ltd.
Bionichive Ltd. Auto Parts: OEMProducer Manufacturing Bionichive Ltd. introduces Squid, a fully automated, autonomous robotic solution that combines the intelligence and flexibility of humans with the power and efficiency of robots. The company is based in Ein Habsor, Israel. The Israeli company's solution is capable of pick and put-away, floor to ceiling and retrofits onto any existing warehouse. A high-end embedded control system and smart real-time data analysis allows Bionichive’s algorithmic engine to dynamically learn problems created in one warehouse and apply resolutions to all warehouses in the network. Bionichive offers a solution based on a fleet of autonomous robots, capable of floor to ceiling pick and put-away while working alongside the labor force on existing operations. | Producer Manufacturing |
Alma Bio Therapeutics
Alma Bio Therapeutics Miscellaneous Commercial ServicesCommercial Services Alma Bio Therapeutics is a French company that aims to restore immune resilience in patients suffering from autoimmune diseases. The private company's therapeutic approach employs the language of the immune system to improve patients' health by targeting the underlying cause of the disease. The company's treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission. Alma Bio Therapeutics has developed a breakthrough therapy that is targeted, specific, and confined to the site of disease, reinstating immune balance with no overdrive or complete suppression. The company's platform-technology is applicable to several autoimmune diseases, promising to yield a versatile pipeline. The company's lead programs are directed towards diseases of complex etiology in areas of significant unmet clinical need, with inflammatory bowel disease (IBD) as their first clinical indication. Alma Bio Therapeutics is led by a seasoned management team with extensive expertise in business development, drug development, and technology commercialization. | Commercial Services |
